【4574】大幸薬品

製薬。『正露丸』

類似企業：

【業界1位】小野薬品工業

【売上同水準】わかもと製薬 中京医薬品

東証プライム

医薬品医薬

＞

その他医療・医薬品医他

売上高

営業利益

経常利益

当期利益

業績予想修正

対前回修正率

当初予想比較

決算期	日付	予・実	売上高 (百万円)	対前回	修正率	修正率	営業利益 (百万円)	対前回	修正率	修正率	経常利益 (百万円)	対前回	修正率	修正率	当期利益 (百万円)	対前回	修正率	修正率
2025.12	2025/02/13	当初予	6,300	-	-	-	215	-	-	-	200	-	-	-	300	-	-	-
2024.12	2025/02/13	実	6,292	↓	-7.5%	-7.5%	629	↑	+14.4%	+53.4%	688	↑	+16.6%	+67.8%	898	↑	+63.3%	+156.6%
2024.12	2024/11/08	Q3予	6,800	→	0.0%	0.0%	550	→	0.0%	+34.1%	590	→	0.0%	+43.9%	550	→	0.0%	+57.1%
2024.12	2024/08/09	Q2予	6,800	→	0.0%	0.0%	550	↑	+34.1%	+34.1%	590	↑	+63.9%	+43.9%	550	→	0.0%	+57.1%
2024.12	2024/05/10	Q1予	6,800	→	0.0%	0.0%	410	→	0.0%	0.0%	360	→	0.0%	-12.2%	550	→	0.0%	+57.1%
2024.12	2024/03/07	修正予	6,800	→	0.0%	0.0%	410	→	0.0%	0.0%	360	↓	-12.2%	-12.2%	550	↑	+57.1%	+57.1%
2024.12	2024/02/09	当初予	6,800	-	-	-	410	-	-	-	410	-	-	-	350	-	-	-
2023.12	2024/02/09	実	6,120	↓	-4.4%	-22.5%	-1,005	↓	-25.6%	-288.9%	-1,248	↓	-24.8%	-334.6%	-3,611	↓	-280.1%	-7322.0%
2023.12	2023/11/10	Q3予	6,400	↓	-19.0%	-19.0%	-800	↓	-250.4%	-250.4%	-1,000	↓	-1766.7%	-288.0%	-950	↓	-2000.0%	-2000.0%
2023.12	2023/08/10	Q2予	7,900	→	0.0%	0.0%	532	→	0.0%	0.0%	60	→	0.0%	-88.7%	50	→	0.0%	0.0%
2023.12	2023/05/12	Q1予	7,900	→	0.0%	0.0%	532	→	0.0%	0.0%	60	↓	-88.7%	-88.7%	50	→	0.0%	0.0%
2023.12	2023/02/10	当初予	7,900	-	-	-	532	-	-	-	532	-	-	-	50	-	-	-
2022.12	2023/02/10	実	5,040	↓	-16.0%	-16.0%	-3,079	↓	-10.0%	-10.0%	-3,352	↓	-11.7%	-11.7%	-4,895	↓	-48.3%	-48.3%
2022.12	2022/11/11	Q3予	6,000	→	0.0%	0.0%	-2,800	→	0.0%	0.0%	-3,000	→	0.0%	0.0%	-3,300	→	0.0%	0.0%
2022.12	2022/08/12	当初予	6,000	-	-	-	-2,800	-	-	-	-3,000	-	-	-	-3,300	-	-	-
2021.12	2022/02/18	実	11,299	↓	-9.6%	-48.6%	-4,947	↓	-147.4%	-209.9%	-6,131	↓	-80.3%	-239.3%	-9,594	↓	-242.6%	-409.5%
2021.12	2021/11/09	Q3予	12,500	→	0.0%	-43.2%	-2,000	→	0.0%	-144.4%	-3,400	→	0.0%	-177.3%	-2,800	→	0.0%	-190.3%
2021.12	2021/08/06	Q2予	12,500	↓	-43.2%	-43.2%	-2,000	↓	-144.4%	-144.4%	-3,400	↓	-177.3%	-177.3%	-2,800	↓	-190.3%	-190.3%
2021.12	2021/05/07	Q1予	22,000	→	0.0%	0.0%	4,500	→	0.0%	0.0%	4,400	→	0.0%	0.0%	3,100	→	0.0%	0.0%
2021.12	2021/02/12	当初予	22,000	-	-	-	4,500	-	-	-	4,400	-	-	-	3,100	-	-	-
2020.12	2021/02/12	実	17,582	↓	-2.3%	+30.2%	5,650	↑	+2.7%	+52.7%	5,454	↑	+2.9%	+55.8%	3,851	↑	+1.3%	+54.0%
2020.12	2020/11/12	Q2予	18,000	→	0.0%	+33.3%	5,500	→	0.0%	+48.6%	5,300	→	0.0%	+51.4%	3,800	→	0.0%	+52.0%
2020.12	2020/08/12	修正予	18,000	↑	+33.3%	+33.3%	5,500	↑	+48.6%	+48.6%	5,300	↑	+51.4%	+51.4%	3,800	↑	+52.0%	+52.0%
2020.12	2020/05/12	当初予	13,500	-	-	-	3,700	-	-	-	3,500	-	-	-	2,500	-	-	-
2020.03	2020/05/12	実	14,966	↑	+10.0%	+32.9%	3,824	↑	+27.5%	+73.8%	3,633	↑	+32.1%	+86.3%	2,453	↑	+32.6%	+72.7%
2020.03	2020/02/10	修正予	13,600	↑	+20.8%	+20.8%	3,000	↑	+36.4%	+36.4%	2,750	↑	+41.0%	+41.0%	1,850	↑	+30.3%	+30.3%
2020.03	2019/11/08	Q2予	11,260	→	0.0%	0.0%	2,200	→	0.0%	0.0%	1,950	→	0.0%	0.0%	1,420	→	0.0%	0.0%
2020.03	2019/08/09	Q1予	11,260	→	0.0%	0.0%	2,200	→	0.0%	0.0%	1,950	→	0.0%	0.0%	1,420	→	0.0%	0.0%
2020.03	2019/05/14	当初予	11,260	-	-	-	2,200	-	-	-	1,950	-	-	-	1,420	-	-	-
2019.03	2019/05/14	実	10,418	↑	+0.2%	+11.3%	2,029	↑	+1.4%	+24.5%	1,885	↑	+1.9%	+31.8%	1,415	↑	+1.1%	+40.1%
2019.03	2019/03/15	修正予	10,400	↑	+11.1%	+11.1%	2,000	↑	+22.7%	+22.7%	1,850	↑	+29.4%	+29.4%	1,400	↑	+38.6%	+38.6%
2019.03	2019/02/08	Q3予	9,360	→	0.0%	0.0%	1,630	→	0.0%	0.0%	1,430	→	0.0%	0.0%	1,010	→	0.0%	0.0%
2019.03	2018/11/09	Q2予	9,360	→	0.0%	0.0%	1,630	→	0.0%	0.0%	1,430	→	0.0%	0.0%	1,010	→	0.0%	0.0%
2019.03	2018/08/10	Q1予	9,360	→	0.0%	0.0%	1,630	-	-	-	1,430	→	0.0%	0.0%	1,010	→	0.0%	0.0%
2019.03	2018/05/11	当初予	9,360	-	-	-	-	-	-	-	1,430	-	-	-	1,010	-	-	-
2018.03	2018/05/11	実	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
2018.03	2018/02/09	Q3予	8,700	→	0.0%	0.0%	1,550	→	0.0%	0.0%	1,300	→	0.0%	0.0%	900	→	0.0%	0.0%
2018.03	2017/11/10	Q2予	8,700	→	0.0%	0.0%	1,550	→	0.0%	0.0%	1,300	→	0.0%	0.0%	900	→	0.0%	0.0%
2018.03	2017/08/10	Q1予	8,700	→	0.0%	0.0%	1,550	→	0.0%	0.0%	1,300	→	0.0%	0.0%	900	→	0.0%	0.0%
2018.03	2017/05/12	当初予	8,700	-	-	-	1,550	-	-	-	1,300	-	-	-	900	-	-	-
2017.03	2017/05/12	実	8,294	↓	-1.3%	-1.3%	1,545	↑	+14.4%	+14.4%	1,407	↑	+26.8%	+26.8%	1,049	↑	+23.4%	+23.4%
2017.03	2017/02/10	Q3予	8,400	→	0.0%	0.0%	1,350	→	0.0%	0.0%	1,110	→	0.0%	0.0%	850	→	0.0%	0.0%
2017.03	2016/11/11	Q2予	8,400	→	0.0%	0.0%	1,350	→	0.0%	0.0%	1,110	→	0.0%	0.0%	850	→	0.0%	0.0%
2017.03	2016/08/12	Q1予	8,400	→	0.0%	0.0%	1,350	→	0.0%	0.0%	1,110	→	0.0%	0.0%	850	→	0.0%	0.0%
2017.03	2016/05/13	当初予	8,400	-	-	-	1,350	-	-	-	1,110	-	-	-	850	-	-	-
2016.03	2016/05/13	実	8,327	↓	-9.5%	-9.5%	1,347	↓	-13.1%	-13.1%	1,307	↓	-9.9%	-9.9%	840	↓	-16.0%	-16.0%
2016.03	2016/02/12	Q3予	9,200	→	0.0%	0.0%	1,550	→	0.0%	0.0%	1,450	→	0.0%	0.0%	1,000	→	0.0%	0.0%
2016.03	2015/11/12	Q2予	9,200	→	0.0%	0.0%	1,550	→	0.0%	0.0%	1,450	→	0.0%	0.0%	1,000	→	0.0%	0.0%
2016.03	2015/08/12	Q1予	9,200	→	0.0%	0.0%	1,550	→	0.0%	0.0%	1,450	→	0.0%	0.0%	1,000	→	0.0%	0.0%
2016.03	2015/05/13	当初予	9,200	-	-	-	1,550	-	-	-	1,450	-	-	-	1,000	-	-	-
2015.03	2015/05/13	実	8,978	↑	+0.9%	+9.5%	2,559	↑	+16.3%	+64.0%	2,776	↑	+18.1%	+77.9%	1,770	↑	+18.0%	+77.0%
2015.03	2015/02/12	Q3予	8,900	→	0.0%	+8.5%	2,200	→	0.0%	+41.0%	2,350	→	0.0%	+50.6%	1,500	→	0.0%	+50.0%
2015.03	2015/02/05	修正予	8,900	↑	+8.5%	+8.5%	2,200	↑	+41.0%	+41.0%	2,350	↑	+50.6%	+50.6%	1,500	↑	+50.0%	+50.0%
2015.03	2014/11/12	Q2予	8,200	→	0.0%	0.0%	1,560	→	0.0%	0.0%	1,560	→	0.0%	0.0%	1,000	→	0.0%	0.0%
2015.03	2014/08/12	Q1予	8,200	→	0.0%	0.0%	1,560	→	0.0%	0.0%	1,560	→	0.0%	0.0%	1,000	→	0.0%	0.0%
2015.03	2014/05/13	当初予	8,200	-	-	-	1,560	-	-	-	1,560	-	-	-	1,000	-	-	-
2014.03	2014/05/13	実	9,947	↑	+8.1%	+8.1%	2,590	↑	+17.7%	+17.7%	2,683	↑	+19.2%	+19.2%	1,747	↑	+21.3%	+21.3%
2014.03	2014/02/05	当初予	9,200	-	-	-	2,200	-	-	-	2,250	-	-	-	1,440	-	-	-

【4574】大幸薬品 製薬。『正露丸』 類似企業： 【業界1位】 小野薬品工業 【売上同水準】 わかもと製薬 中京医薬品

【4574】大幸薬品

製薬。『正露丸』

類似企業：

【業界1位】小野薬品工業

【売上同水準】わかもと製薬中京医薬品